NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioHarv

BioHarv

Private
LondonHealthcare & Life Scienceshttps://bio-harv.replit.app/

Last Round

Series D

Mar 11, 2026

Est. Valuation

$9B

Total Funding Raised

$852.02M

Company Overview

BioHarv is a biotechnology company developing battery-free, energy-harvesting implantable sensors for continuous cardiac monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

implantable cardiac sensorsenergy harvestingbattery-free implantscardiac monitoringpiezoelectric sensorsbiomedical electronicsmedtechbioelectronicsimplantable medical devicesheart failure managementbiocompatible sensorsultra-low-power ASICsASICsmart implantsdeep tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioHarv Comparables

Compare BioHarv with similar companies based on industry and business-model similarity.

BioHarv comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Celtro GmbH
75%
Medtronic
73%
Edwards Lifesciences
72%

BioHarv Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMar 11, 2026
Series CJul 30, 2025
Series B ExtensionApr 25, 2023
Series BDec 8, 2021
Series AFeb 18, 2021
Seed
Oct 22, 2018

BioHarv Investors

Notable investors and investment history

BioHarv investors
InvestorRounds
Andreessen HorowitzSeries D, Series A, Seed
SV AngelSeries B Extension
GeorgianSeries D
Khosla VenturesSeries B Extension
Craft VenturesSeries D
Okta VenturesSeries D
Accenture VenturesSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2026

    Monthly visitors increased 34% MoM, reaching 4 million.

  • Dec 8, 2021

    $80M round led by Coatue Management.

BioHarv Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioHarv Filings

SEC and related filings with document metadata.

Appears On

Curated lists and screens where this company is featured.

Frequently Asked Questions

Common questions about BioHarv's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range44
Year Founded2024
Last FundingMar 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.